Call Today for a FREE Confidential Case Review - Toll-Free 24/7 (866) 920-0753

Judge Rejects Claims in Generic Testosterone Drug Lawsuits

Judge Rejects Claims in Generic Testosterone Drug Lawsuits

November 13, 2015 — Law360 reports that a federal judge has rejected failure-to-warn claims involving Testopel and Depo-Testosterone because drug-makers did not have the authority to unilaterally strengthen the labels.

Testopel and Depo-Testosterone were given expedited approval based on their similarity to brand-name testosterone drugs, and are therefore “generic.” Any changes to generic drug labels must be approved by the FDA.

Because generic drug-makers can’t unilaterally warn about new risks, failure-to-warn claims under state law are preempted by federal law. Lawsuits involving brand-name drugs like AndroGel are not affected because the FDA does not need to pre-approve stronger warning labels.

U.S. District Judge Matthew Kennelly dismissed claims accusing Pfizer and Auxilium Pharmaceuticals of failing to adequately warn about the risk of heart attacks and strokes from Testopel or Depo-Testosterone.

Judge Kennelly oversees about 2,700 lawsuits involving nearly a dozen different testosterone therapy products. The cases have been centralized in a federal Multi-District Litigation (MDL No. 2545) in Illinois.

The FDA began investigating the safety of testosterone therapy last year after several studies found higher rates of heart attack, stroke, and death among men over 60.

The agency has ordered drug-makers to add warnings about venous blood clots, pulmonary embolism, deep vein thrombosis, venous thromboembolism, heart attacks, and stroke. The FDA has also asked drug-makers to stop marketing testosterone for age-related symptoms of “Low T” and start studying long-term side effects.

Do I have a Testosterone Injury Lawsuit?

The Schmidt Firm, PLLC is currently accepting testosterone induced injury cases in all 50 states. If you or somebody you know had a heart attack or stroke, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.

Free Case Evaluation

The Schmidt Firm, PLLC has been recognized as one of the nation’s leading plaintiff’s law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firms reputation for providing personal attention to each and every client we represent.

No matter what type of case you have, you may contact us with confidence by filling out the email contact form below or calling us directly by dialing toll free 24 hrs/day (866) 920-0753.